Horizon Pharma plc Uncategorized Contracts & Agreements
30 Contracts & Agreements
- Appendix 3 to the Rule 2.7 Announcement, dated as of December 12, 2022 (Conditions Appendix) (Filed With SEC on December 12, 2022)
- Transaction Agreement, dated as of December 11, 2022, by and among Amgen Inc., Pillartree Limited and Horizon Therapeutics plc (Filed With SEC on December 12, 2022)
- Description of securities registered under Section 12 of the Exchange Act of 1934 (Filed With SEC on February 26, 2020)
- Rights Agreement, dated as of February 28, 2019, between Horizon Pharma Public Limited Company and Computershare Trust Company, N.A (Filed With SEC on February 28, 2019)
- (hereinafterreferred to as HORIZON) (Filed With SEC on August 7, 2017)
- AMENDMENT (Filed With SEC on February 27, 2017)
- LICENSEAGREEMENT (Filed With SEC on February 29, 2016)
- - 1 - (Filed With SEC on February 29, 2016)
- TENDER AND SUPPORT AGREEMENT (Filed With SEC on March 31, 2015)
- Dated the 16th day of April 2012 BENTON PROPERTY HOLDING LIMITED (IN RECEIVERSHIP) (1) and JIM HAMILTON (2) and VIDARA THERAPEUTICS (3) LICENCE AGREEMENT Re: Unit Nos. 202 and 203... (Filed With SEC on February 27, 2015)
- REVENUE ADJUSTMENT AGREEMENT BY AND BETWEEN INTERMUNE PHARMACEUTICALS, INC. AND CONNETICSCORPORATION JUNE 27, 2000 REVENUE ADJUSTMENT AGREEMENT (Filed With SEC on February 27, 2015)
- Dated the 4th day of November 2014 JOHN RONAN AND CASTLE COVE PROPERTY DEVELOPMENTS LIMITED (Filed With SEC on February 27, 2015)
- Deerfield Management Company, L.P. 780 Third Avenue, 37th Floor NewYork, NY 10017 (Filed With SEC on March 19, 2014)
- MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED Mundipharma House -14, Par-la-Ville Road - P.O. Box HM 2332 - Hamilton HM JX -Bermuda Tel: (441) 295-6480 - Fax: (441) 292-1472 a... (Filed With SEC on May 10, 2013)
- MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED Mundipharma House -14, Par-la-Ville Road - P.O. Box HM 2332 - Hamilton HM JX -Bermuda Tel: (441) 295-6480 - Fax: (441) 292-1472 a... (Filed With SEC on May 10, 2013)
- Horizon Pharma, Inc. Amended and Restated Non-Employee DirectorCompensation Policy Amended Effective: December 14, 2012 (Filed With SEC on March 18, 2013)
- CO-PROMOTION AGREEMENT (Filed With SEC on August 10, 2012)
- CONVERSION AND AMENDMENT AGREEMENT (Filed With SEC on July 11, 2011)
- 1033 Skokie Boulevard, Suite 355 Northbrook, IL 60062 (Filed With SEC on June 7, 2011)
- 1033 Skokie Boulevard, Suite 355 Northbrook, IL 60062 (Filed With SEC on June 7, 2011)
- CONFIDENTIAL (Filed With SEC on June 7, 2011)
- [Signatures next page] (Filed With SEC on April 1, 2011)
- TECHNICAL TRANSFER AGREEMENT (Filed With SEC on October 21, 2010)
- Technology Transfer Agreement between Merck KGaA (Merck), Frankfurter Strasse 250, 64271 Darmstadt and Nitec Pharma AG (Nitec Pharma) Switzerland Preamble (Filed With SEC on October 21, 2010)
- [Signatures next page] (Filed With SEC on October 8, 2010)
- TECHNICAL TRANSFER AGREEMENT (Filed With SEC on August 3, 2010)
- MUNDIPHARMA INTERNATIONALCORPORATION LIMITED Mundipharma House 14, Par-la-Ville Road P.O. Box HM 2332 Hamilton HM JX Bermuda Tel: (441) 295-6480 Fax: (441) 292-1472 a member of... (Filed With SEC on August 3, 2010)
- Agreement between Merck Pharma GmbH Alsfelder Straße 17 64289 Darmstadt, Germany (Merck) and NitecPharma AG Kägenstraße 17 4153 Reinach, Switzerland (Nitec AG) and NitecGmbH... (Filed With SEC on August 3, 2010)
- Technology Transfer Agreement between Merck KGaA (Merck), Frankfurter Strasse 250, 64271 Darmstadt and NitecPharma AG (Nitec Pharma) Switzerland Preamble (Filed With SEC on August 3, 2010)
- HORIZON PHARMA, INC. INDEMNITY AGREEMENT (Filed With SEC on August 3, 2010)
